Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence.
about
Hormone therapy for preventing cardiovascular disease in post-menopausal womenHormone therapy for preventing cardiovascular disease in post-menopausal womenSteroid sex hormones for lower limb atherosclerosisHormone replacement therapy for preventing cardiovascular disease in post-menopausal womenData dredging, bias, or confoundingEstrogen receptor transcription and transactivation: Basic aspects of estrogen action.Do we need clinical trials to test the ability of transdermal HRT to prevent coronary heart disease?Changes in elderly women's health-related quality of life following discontinuation of hormone replacement therapy.Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73)Downregulation of miR-151-5p contributes to increased susceptibility to arrhythmogenesis during myocardial infarction with estrogen deprivationPostmenopausal hormones and coronary artery disease: potential benefits and risksWomen's attitudes to hormone replacement therapy in the aftermath of the Women's Health Initiative studyIncreased leukocyte ABCA1 gene expression in post-menopausal women on hormone replacement therapyComparing hormone therapy effects in two RCTs and two large observational studies that used similar methods for comprehensive data collection and outcome assessment.An analytic framework for aligning observational and randomized trial data: Application to postmenopausal hormone therapy and coronary heart disease.Rapid changes in cardiac myofilament function following the acute activation of estrogen receptor-alpha.Cardiovascular effects of tamoxifen in women with and without heart disease: breast cancer prevention trial. National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial Investigators.Time since menopause does not affect plasma viscosity, plasma thromboxane levels and Doppler findings.Breast cancer risk associated with different HRT formulations: a register-based case-control study.The Women's international study of long-duration oestrogen after menopause (WISDOM): a randomised controlled trial.Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies.Data analysis methods and the reliability of analytic epidemiologic researchThe Asp298 allele of endothelial nitric oxide synthase is a risk factor for myocardial infarction among patients with type 2 diabetes mellitusHormone replacement therapy for the primary prevention of chronic diseases: recommendation statement from the Canadian Task Force on Preventive Health CareA randomised controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritisPhyto-oestrogens: a potential role in the prevention of CHD?Benefits and risks of hormone replacement therapy in young adult cancer survivors with gonadal failure.Hormone replacement therapy: characteristics of users and non-users in a British general practice cohort identified through computerised prescribing records.Why do women doctors in the UK take hormone replacement therapy?Gender and vascular reactivity.Folic Acid Supplementation Delays Atherosclerotic Lesion Development by Modulating MCP1 and VEGF DNA Methylation Levels In Vivo and In VitroPostmenopausal hormone therapy, SERMs, and coronary heart disease in women.Ethnic differences in hormone replacement prescribing patternsThe impact of estrogen replacement therapy and raloxifene on osteoporosis, cardiovascular disease, and gynecologic cancers.Usefulness of Mendelian randomization in observational epidemiology.Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.Steroid sex hormones for lower limb atherosclerosis.Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase.Modification of serum lipids and cardiovascular risk by estrogenic active compounds.Migraine, menopause and hormonal replacement therapy.
P2860
Q24187326-87C30062-558B-4C91-953F-F6E1D408CE1BQ24197712-B02850CF-DDF2-48EF-8DD2-FA1437A4B8C4Q24198081-C83A41C9-3635-45D8-97ED-D38EDD008FD2Q24244146-B183E20B-A6E0-4273-9735-E6E8389DB16DQ24527231-80C53651-9CD9-49A2-9E22-319A40B951A4Q24800814-781A7A5F-3D15-4D5F-8DD3-19F883BBE4BBQ24806978-15B79F69-BF7B-46EB-A1FA-780B4150D5B8Q24814779-ACF1D1BE-6BFC-4096-A470-F43BF4B1BA99Q26748842-137297E2-C0A5-457E-A655-B57D9D4BF9CDQ27308514-3AE523CC-BF43-4D92-AEF0-6B12B8E9FD09Q28221869-A8085A8E-81C2-4AF8-BECB-44347B60531DQ28242100-0CC87A25-895F-489A-84E0-2E203D2BDAA8Q28292147-EF93B7D6-7375-4467-8577-5413CB84B6F8Q30655662-2BB55C42-894B-4774-83FB-E9D47458D27BQ30696956-510B89CB-71F4-48E0-BE28-13D212D7DCBAQ31079547-B01DCD94-EF0C-49CC-8D4E-549725E2705BQ31797579-D3AA950B-35C3-42F8-8A32-E17A0FE99807Q33219514-1261F310-C660-4793-B63A-C27EB2D59030Q33257142-709401AF-E055-4F7F-B3F1-B78E4E8AA443Q33275630-FE46FCE0-C628-47A9-BE34-BE8684D6031FQ33329705-381C3F66-121D-4371-BA8D-C3CCB3F6AFB3Q33371496-F55B9EF9-BBB8-4826-A7BB-41862F0E8C76Q33392407-D39B1578-7293-49A4-8FA9-51B55878A06FQ33554786-C5B6CAF3-D046-44B5-9651-FBACE7A65CFBQ33566104-3779CB7F-2434-4AB2-88C4-BA74B6F0DA8BQ33644539-2D6AED37-3779-4313-BAC5-AD60B205BF88Q33684739-7DD83C9C-7EE3-4E96-B12A-070B9D924907Q33703041-B66AE852-EE04-4855-BB77-FBFA66DF58A6Q33704462-9B4B10A5-F102-4BB3-8B5E-2D5BB2737FC2Q33716546-D2E95572-6241-4C81-90D6-3E6E9192A1DCQ33755060-502DDFAE-82EF-43A1-8F6A-274519C5780CQ33757741-605308D3-3068-4B1A-B0C0-8BE3EEF984D8Q33778878-D1C010FC-C36F-478A-A4AC-CC6463FAAF95Q33814554-6E258F44-DFCD-4FE3-B334-F10ECB74B705Q33858805-8266C8A0-C376-48F1-86E2-E006FE503FBDQ33885656-DE11F0EC-D623-436A-9622-C1FB02E23D62Q33908587-852E94EC-02B4-47F4-B77D-3EE368B3163AQ33937883-33D2DA1F-C465-451A-B81F-9B22E3EA9781Q33947465-3C37C352-6DE5-4DB8-8926-94FB8F546FDFQ34039852-EABC994C-0900-44D9-A621-EC36DEAB4E25
P2860
Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence.
description
1991 nî lūn-bûn
@nan
1991 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Estrogen replacement therapy a ...... of the epidemiologic evidence.
@ast
Estrogen replacement therapy a ...... of the epidemiologic evidence.
@en
Estrogen replacement therapy a ...... of the epidemiologic evidence.
@nl
type
label
Estrogen replacement therapy a ...... of the epidemiologic evidence.
@ast
Estrogen replacement therapy a ...... of the epidemiologic evidence.
@en
Estrogen replacement therapy a ...... of the epidemiologic evidence.
@nl
prefLabel
Estrogen replacement therapy a ...... of the epidemiologic evidence.
@ast
Estrogen replacement therapy a ...... of the epidemiologic evidence.
@en
Estrogen replacement therapy a ...... of the epidemiologic evidence.
@nl
P1433
P1476
Estrogen replacement therapy a ...... of the epidemiologic evidence.
@en
P2093
Colditz GA
Stampfer MJ
P356
10.1016/0091-7435(91)90006-P
P407
P577
1991-01-01T00:00:00Z